Author: Dr. Mahdi Khazaei
Are Healthcare ETFs Ready for a Comeback or Just Catching Their Breath?
For much of 2025, healthcare stocks have looked tired. The S&P 500
Pharmacies Are Becoming Canada’s New Front Door to Primary Care
On a Friday morning in Surrey a Shoppers Drug Mart pharmacist is
Weight-Loss Pills Are Coming. What It Means for Investors
For the past two years, the biggest story in healthcare investing has
Medical Device ETFs Get a Lift from Surgery’s Return and a Wave of Acquisitions
When elective surgery schedules collapsed during the pandemic, exchange...
Gene Editing Cashes In: Casgevy’s First Sales Signal the Commercial Dawn of DNA-Editing Technology
Nineteen-year-old Deshawn “DJ” Chow spent the opening weeks of 2025 at...